Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00159
|
|||||
| Drug Name |
Paliperidone
|
|||||
| Synonyms |
Invega Sustenna; JNS-010; Paliperidone (depot injection, NanoCrystal); Paliperidone (depot injection, NanoCrystal), Johnson & Johnson; Paliperidone (injectable, NanoCrystal), Elan; Paliperidone palmitate; Xeplion
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Schizophrenia [ICD11: 6A20] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H27FN4O3
|
|||||
| Canonical SMILES |
CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
|
|||||
| InChI |
InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3
|
|||||
| InChIKey |
PMXMIIMHBWHSKN-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 199739-10-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 426.5 | Topological Polar Surface Area | 82.2 | ||
| Heavy Atom Count | 31 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10236700
, 103604037
, 103910909
, 104105311
, 104397925
, 118046559
, 121361150
, 125307525
, 125341102
, 126584511
, 126621140
, 126649064
, 126650388
, 126667060
, 128939139
, 131465791
, 131549340
, 134338126
, 135072932
, 136367845
, 137166111
, 142528484
, 144116334
, 14905143
, 152258953
, 152344196
, 160647798
, 160810375
, 160964597
, 162185890
, 163088563
, 163371020
, 163564516
, 163981461
, 164175255
, 164785605
, 170501956
, 171063034
, 22395187
, 29296762
, 46506296
, 47207025
, 50035150
, 51002222
, 57339070
, 85229944
, 85246150
, 90341688
, 92719038
, 92729808
|
|||||
| ChEBI ID |
CHEBI:83804
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Paliperidone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Invega (paliperidone) extended release tablets FDA Label | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.